Key statistics
On Friday, Annexon Inc (ANNX:NSQ) closed at 4.89, -31.89% below its 52-week high of 7.18, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 5.22 |
|---|---|
| High | 5.37 |
| Low | 4.87 |
| Bid | 4.90 |
| Offer | 5.27 |
| Previous close | 5.19 |
| Average volume | 2.10m |
|---|---|
| Shares outstanding | 144.55m |
| Free float | 134.33m |
| P/E (TTM) | -- |
| Market cap | 706.83m USD |
| EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Announcements
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
- Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
- Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
- Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
- Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
- Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
- Annexon Biosciences to Participate in Upcoming September Investor Conferences
More ▼
